Stem Cell Implants Could Cure Diabetes | Healthcare Packaging
ViaCyte cure for diabetes. Most promising research – Fixic Patch
Islet Cell Replacement Therapy for Insulin-Dependent Diabetes - CADTH Issues in Emerging Health Technologies - NCBI Bookshelf
Filming the ViaCyte Type 1 Cell Experiment | Insulin Nation
Stem Cell-derived Treatment One Step Closer to Type 1 Diabetes Cure
Vertex buys ViaCyte for $320M, clearing out T1D competition
ViaCyte receives funding towards 'functional cure' for diabetes
Can CRISPR Therapeutics (CRSP) and ViaCyte CURE Type 1 Diabetes? | VCTX210 - YouTube
The Human Trial' Review: The Race for a Diabetes Cure - The New York Times
Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more - The Niche
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy | BioSpace
Exciting news: stem cell-based treatments producing insulin in participants with type 1 diabetes | JDRF Canada
Sweet Spot: CRISPR Therapeutics, ViaCyte Dose First Patient with Cell Therapy for Type 1 Diabetes
Johnson and Johnson, ViaCyte testing possible diabetes cure | CTV News
ViaCyte's Sweet Three-Pronged Attack against Type 1 Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes | Bain Capital
The Human Trial' depicts cost of Type 1 Diabetes and grueling effort to find a cure | Here & Now
Vertex to acquire ViaCyte, targeting type 1 diabetes
ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate
Will ViaCyte's Encaptra Cell Delivery System 'Cure' Type 1 Diabetes? | Insulin Nation
CRISPR Therapeutics and ViaCyte Tackling Type 1 Diabetes - YouTube
Vertex Pays CRISPR Therapeutics $100M to Bring Gene-Editing to Type 1 Diabetes - MedCity News
ViaCyte and CRISPR Introduce New Stem Cell Therapy for Type 1 Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
